N06BA04 - Methylphenidate |
Propably not porphyrinogenic |
PNP |
Rationale
Not CYP-metabolised. No data pointing to CYP-induction. References consider it safe.
Chemical description
(To be edited, initial data ST OCT 04) Narcotic psychostimulant used in treatment of attention deficit hyperactivity (ADH). Metabolized by de-esterification to alphaphenylpiperidine acetic acid. No data pointing to CYP-induction. EPI-list: safe. South African list: use. Australian list: safe.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
© NAPOS 2024